z-logo
open-access-imgOpen Access
Major histocompatibility complex class‐ II molecules promote targeting of human immunodeficiency virus type 1 virions in late endosomes by enhancing internalization of nascent particles from the plasma membrane
Author(s) -
Finzi Andrés,
Perlman Mira,
BourgeoisDaigneault MarieClaude,
Thibodeau Jacques,
Cohen Éric A.
Publication year - 2013
Publication title -
cellular microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.542
H-Index - 138
eISSN - 1462-5822
pISSN - 1462-5814
DOI - 10.1111/cmi.12074
Subject(s) - endosome , internalization , endocytic cycle , endocytosis , microbiology and biotechnology , biology , cell membrane , major histocompatibility complex , virology , cell , antigen , immunology , biochemistry , intracellular
Summary Productive assembly of human immunodeficiency virus type 1 ( HIV ‐1) takes place, primarily, at the plasma membrane. However, depending on the cell types, a significant proportion of nascent virus particles are internalized and routed to late endosomes. We previously reported that expression of human leucocyte antigen ( HLA )‐ DR promoted a redistribution of G ag in late endosomes and an increased detection of mature virions in these compartments in H e L a and human embryonic kidney 293 T model cell lines. Although this redistribution of G ag resulted in a marked decrease of HIV ‐1 release, the underlying mechanism remained undefined. Here, we provide evidence that expression of HLA‐DR at the cell surface induces a redistribution of mature G ag products into late endosomes by enhancing nascent HIV ‐1 particle internalization from the plasma membrane through a process that relies on the presence of intact HLA‐DR α and β‐chain cytosolic tails. These findings raise the possibility that major histocompatibility complex class‐ II molecules might influence endocytic events at the plasma membrane and as a result promote endocytosis of progeny HIV ‐1 particles.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here